Wanbury Ltd
Pharmaceuticals & Biotechnology | Small Cap
Wanbury Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by high return on capital employed and return on assets. Growth is supported by significant increases in operating profit and assets. However, the company faces challenges in liquidity, efficiency, and certain financial metrics, particularly related to earnings per share and revenue growth. Coverage ratios are moderate, indicating an ability to meet interest obligations but a lack of dividend coverage. Overall, Wanbury Ltd exhibits potential for sustained profitability and asset expansion, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio4.00
- Profitability Ratio4.80
- Efficiency Ratio4.67
- Coverage Ratio4.40
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Wanbury Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by high return on capital employed and return on assets. Growth is supported by significant increases in operating profit and assets. However, the company faces challenges in liquidity, efficiency, and certain financial metrics, particularly related to earnings per share and revenue growth. Coverage ratios are moderate, indicating an ability to meet interest obligations but a lack of dividend coverage. Overall, Wanbury Ltd exhibits potential for sustained profitability and asset expansion, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Overall Valuation Score
P/E RATIO (TTM)
14.09
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
28.62
P/B RATIO
14.74
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
1.47
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.00
EV/EBITDA RATIO
12.92
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹266.75 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth metrics indicate a mixed performance. While the company shows significant growth in operating profit and assets, revenue and net income growth rates are low. There is a need to improve revenue generation to ensure balanced and sustainable growth across all key areas.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 6.81 | 30.36 | -5.09 | 19.18 | 3.81 |
| Operating Profit Growth Rate | -21.74 | 100 | -27.78 | 188.46 | 6.67 |
| Earnings Per Share (EPS) Growth | -119.54 | -594.84 | -112.75 | -637.42 | -45.47 |
| Asset Growth Rate | 3.58 | 22.15 | -13.88 | 12.83 | 20.7 |
| Net Income Growth Rate | -120.31 | -723.08 | -112.35 | -660 | -44.64 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial metrics show mixed results. While capital expenditures are well-managed, adjusted earnings per share, book value per share, and dividend per share are low. This could impact investor perception and long-term financial health. Improving key financial indicators is essential for maintaining investor confidence.
| Financial Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | -5.06 | 1.6 | -1.94 | 10.08 | 10.25 |
| Cash Earnings Per Share (Cash EPS) | -1.2 | 27.88 | 0.61 | 20.91 | 13.33 |
| Book Value Per Share | -62.4 | -6.97 | -10 | 8.48 | 17.88 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 4.4 | 1.1 | 12.6 | 13.8 | 48.6 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability metrics present a mixed outlook. While return on capital employed and return on assets are high, gross profit margin, return on equity, operating margin, and net margin are very low. There is a need to improve profit margins to ensure sustained profitability. Enhancing operational efficiency could significantly boost profitability.
| Profitability Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Gross Profit Margin | 2.04 | 4.89 | 2.89 | 10.73 | 11.17 |
| Return on Capital Employed (ROCE) | 27 | 46 | 21 | 61 | 37 |
| Return on Equity (ROE) | 200 | 52.54 | |||
| Return on Assets (ROA) | 6.23 | 10.2 | 8.55 | 21.87 | 19.32 |
| Operating Margin | 4.59 | 7.05 | 5.36 | 12.98 | 13.33 |
| Net Margin | -3.32 | 15.85 | -2.06 | 9.69 | 5.17 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency metrics present a mixed view. While days sales in inventory and receivable days suggest efficient inventory and accounts receivable management, the turnover ratios for fixed assets, inventory, receivables, and capital are very low. This indicates inefficient use of assets in generating sales, impacting overall operational effectiveness. There is a need to improve the utilization of assets to enhance revenue generation.
| Efficiency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.35 | 3.06 | 2.9 | 3.46 | 2.99 |
| Inventory Turnover Ratio | 20.76 | 12.96 | 13.08 | 17.79 | 14.41 |
| Receivables Turnover Ratio | 9.22 | 10.54 | 7.35 | 7.32 | 5.91 |
| Days Sales in Inventory Ratio | 17.58 | 28.16 | 27.91 | 20.52 | 25.33 |
| Receivable Days | 39.59 | 34.63 | 49.66 | 49.86 | 61.76 |
| Capital Turnover Ratio | -7.54 | 46.45 | -242.5 | 4.94 | 2.67 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios indicate moderate strength. While the interest coverage ratio shows an ability to cover interest expenses, the equity dividend coverage ratio is low. This suggests that the company may need to improve its ability to provide returns to shareholders. Balancing interest obligations with shareholder returns is key for financial stability.
| Coverage Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 0.48 | 4.86 | 0.52 | 2.93 | 1.81 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency position appears strong, with debt and debt-to-equity ratios both at very low levels, and a high equity ratio. This suggests a conservative capital structure with minimal debt financing, which reduces financial risk and provides stability. The company's reliance on equity over debt ensures long-term sustainability.
| Solvency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debt Ratio | -2 | 3.09 | -15.5 | 0.76 | 0.74 |
| Debt to Equity Ratio | -0.67 | -1.48 | -0.94 | 3.17 | 2.85 |
| Equity Ratio | 3 | -2.09 | 16.5 | 0.24 | 0.26 |
| Debt To Asset Ratio | 0.36 | 0.1 | 0.1 | 0.26 | 0.4 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reveals challenges, as current, quick, and cash ratios, alongside operating cash flow ratios, are very low. This suggests potential difficulties in meeting short-term obligations. This is a point of concern as it could impact day-to-day operations and the company's ability to respond to immediate financial needs. There is need to improve short term financial health.
| Liquidity Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Current Ratio | 0.33 | 0.53 | 0.44 | 0.77 | 1.1 |
| Quick Ratio | 0.25 | 0.39 | 0.37 | 0.61 | 0.9 |
| Cash Ratio | 0.04 | 0.07 | 0.01 | 0.03 | 0.07 |
| Operating Cash Flow Ratio | 0.05 | 0.12 | 0.07 | 0.02 | 0.14 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 2 | Lincoln Pharmaceuticals Ltd | 7.31 | 14.01 | Neutral | 98.00 | 43.88 | 88.00 |
| 3 | NGL Fine Chem Ltd | 6.98 | 39.22 | Overvalued | 73.00 | 67.39 | 48.00 |
| 4 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 5 | Kilitch Drugs (India) Ltd | 6.61 | 21.54 | Neutral | 37.00 | 9.27 | 30.00 |
| 6 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 7 | SMS Lifesciences India Ltd | 6.59 | 21.20 | Undervalued | 45.00 | 70.68 | 19.00 |
| 8 | Hester Biosciences Ltd | 6.54 | 31.74 | Neutral | 87.00 | 61.24 | 57.00 |
| 9 | Infinium Pharmachem Ltd | 6.42 | 26.90 | Neutral | 22.00 | 6.43 | 14.00 |
| 10 | Sakar Healthcare Ltd | 5.81 | 58.66 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 11 | Medicamen Biotech Ltd | 5.73 | 32.19 | Neutral | 20.00 | 6.94 | 10.00 |
| 12 | Albert David Ltd | 5.63 | -272.47 | Neutral | 5.00 | -2.62 | -1.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.48 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 39.28 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 28.62 | Neutral | 88.00 | 18.93 | 43.00 |
| 17 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
The management of Wanbury Ltd. shows a combination of strengths and weaknesses. The company excels in capital efficiency, demonstrated by high ROCE and ROE, and improving operational efficiency reflected in the OPM %. Sales have generally increased. However, inconsistent profitability and a decreasing promoter holding raise concerns. The management's ability to maintain strong capital efficiency and revenue growth is somewhat offset by profit inconsistencies and ownership structure changes.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | High ROCE | 61.61% | Capital being used productively |
| High ROE | 502.76% | Shareholder funds yielding good returns | |
| OPM Improvement | 17% (Mar 2025) | Improving operational efficiency | |
| CONS | Decreasing Promoter Holding | 39.76% (Mar 2025) | Reduced confidence and alignment with shareholders |
| Profit Volatility | Fluctuating Net Profit | Inconsistent financial performance |
Financial Performance & Growth
Wanbury Ltd. exhibits mixed financial performance. Sales have generally increased, but profit growth is inconsistent. While the operating profit margin (OPM) has improved, net profit fluctuates considerably. The contribution from 'Other Income' also varies, suggesting that profit is not always primarily from core operations.
| Metric | 2016-2018 | 2019-2021 | 2022-2024 | 2025 |
|---|---|---|---|---|
| Sales (Rs. Cr) | 411 | 377 | 518 | 600 |
| Operating Profit (Rs. Cr) | -11 | 20 | 45 | 76 |
| OPM (%) | -2% | 5% | 8% | 13% |
The company's sales have shown a fluctuating trend, with sales in 2016-2018 averaging at 411 Cr, then decreasing to 377 Cr in 2019-2021 before increasing to 518 Cr in 2022-2024 and reaching 600 Cr in 2025. Operating profit was negative at -11 Cr in 2016-2018, but significantly improved to 20 Cr in 2019-2021 and further to 45 Cr in 2022-2024, reaching 76 Cr in 2025. OPM has increased from -2% in 2016-2018 to 5% in 2019-2021 and 8% in 2022-2024, reaching 13% in 2025.
Capital Efficiency & Returns
Wanbury Ltd. displays strong capital efficiency and returns. The Return on Capital Employed (ROCE) and Return on Equity (ROE) are notably high, indicating effective utilization of capital and shareholder funds. The Cash Conversion Cycle is negative, suggesting efficient working capital management.
| Metric | 2016 | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 12% | 26% | 46% | 21% | 61% | 35% |
| ROE (%) | - | - | - | - | 70% | - |
| Cash Conversion Cycle (Days) | -38 | -131 | -113 | -101 | -94 | -55 |
The ROCE % has improved from 12% in 2016 to 61% in 2024, before decreasing to 35% in 2025. The Cash Conversion Cycle is negative, indicating efficient working capital management. The ROE is 70% in 2024.
Financial Health & Prudence
Wanbury Ltd.'s financial health presents a mixed view. While debt has reduced over the years, the company does not pay dividends. The borrowings have been decreasing over the period.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (Rs. Cr) | 377 | 270 | 131 | 95 | 116 | 177 |
Average borrowings have decreased from 377 Cr in 2014-2016 to 270 Cr in 2017-2019 and further to 131 Cr in 2020-2022. In 2023 the borrowings stand at 95Cr which increased to 116 Cr in 2024 and further increased to 177 Cr in 2025. The company's dividend payout stands at 0% from 2014 to 2025.
Shareholding & Ownership Structure
Wanbury Ltd. has experienced a decrease in promoter holding over the years. Institutional holding (FII/DII) is minimal.
| Metric | 2017 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Promoter Holding (%) | 56.11 | 52.13 | 39.89 | 39.84 | 39.79 | 39.76 |
| FII Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | 1.55 |
| DII Holding (%) | 2.43 | 2.14 | 0.00 | 0.00 | 0.00 | 0.00 |
The promoter holding has decreased from 56.11% in 2017 to 39.76% in 2025. FII holding has increased to 1.55% in 2025. DII holding has decreased to 0.00% in 2025.
The risk profile of Wanbury Ltd. is moderate. A negative cash conversion cycle indicates strong working capital management. However, reliance on other income is a concern. The decrease in promoter holding also introduces a risk factor, suggesting reduced alignment between management and shareholders. Overall, while the company demonstrates financial efficiency, these risk factors suggest the need for careful monitoring.
Off-balance sheet exposure quantification
There is no specific data available for off-balance sheet exposure quantification.
Contingent liability evaluation
There is no specific data available for contingent liability evaluation.
Segment performance volatility
There is no specific data available on segment performance volatility.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure.
Regulatory compliance cost trends
There is no specific data available on regulatory compliance cost trends.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10263.27Bullish
- SMA 20264.22Bearish
- SMA 50264.56Bearish
- EMA 10264.24Bearish
- EMA 20264.35Bearish
- EMA 50264.73Bearish
- DEMA 10264.56Bearish
- DEMA 20263.89Bullish
- DEMA 50264.02Bearish
- TEMA 10265.36Bearish
- TEMA 20263.70Bullish
- TEMA 50264.63Bearish
- MACD-0.27Bullish
- ADX17.15Weak Trend
- IndicatorValueSignal
- RSI49.07Neutral
- CCI38.27Neutral
- ROC 91.36Bullish
- ROC 14-0.96Bearish
- ROC 25-0.38Bearish
- Stoch K66.50Neutral
- Stoch D64.58Neutral
- IndicatorValueSignal
- BB Upper270.00Neutral
- BB Middle264.22Neutral
- BB Lower258.44Neutral
- ATR4.51High Volatility
- IndicatorValueSignal
- MFI39.17Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10263.61Bullish
- SMA 20265.62Bearish
- SMA 50262.92Bullish
- EMA 10264.14Bearish
- EMA 20264.43Bearish
- EMA 50265.24Bearish
- DEMA 10263.71Bullish
- DEMA 20264.16Bearish
- DEMA 50263.91Bullish
- TEMA 10263.75Bullish
- TEMA 20264.10Bearish
- TEMA 50262.68Bullish
- MACD-0.29Bearish
- ADX17.96Weak Trend
- IndicatorValueSignal
- RSI49.20Neutral
- CCI-4.71Neutral
- ROC 9-1.51Bearish
- ROC 140.61Bullish
- ROC 252.98Bullish
- Stoch K59.71Neutral
- Stoch D51.02Neutral
- IndicatorValueSignal
- BB Upper272.39Neutral
- BB Middle265.62Neutral
- BB Lower258.85Neutral
- ATR6.26Low Volatility
- IndicatorValueSignal
- MFI38.14Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10265.56Bearish
- SMA 20263.35Bullish
- SMA 50268.92Bearish
- EMA 10264.28Bearish
- EMA 20264.91Bearish
- EMA 50265.12Bearish
- DEMA 10263.80Bullish
- DEMA 20263.53Bullish
- DEMA 50267.91Bearish
- TEMA 10263.54Bullish
- TEMA 20263.36Bullish
- TEMA 50N/AN/A
- MACD-0.92Bullish
- ADX15.06Weak Trend
- IndicatorValueSignal
- RSI48.86Neutral
- CCI33.82Neutral
- ROC 9-2.48Bearish
- ROC 141.87Bullish
- ROC 252.35Bullish
- Stoch K28.57Neutral
- Stoch D27.83Neutral
- IndicatorValueSignal
- BB Upper274.16Neutral
- BB Middle263.35Neutral
- BB Lower252.53Neutral
- ATR9.67Low Volatility
- IndicatorValueSignal
- MFI64.75Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10264.05Bullish
- SMA 20270.18Bearish
- SMA 50262.16Bullish
- SMA 100251.57Bullish
- SMA 200247.63Bullish
- EMA 10265.73Bullish
- EMA 20265.84Bullish
- EMA 50261.44Bullish
- EMA 100255.36Bullish
- EMA 200250.86Bullish
- DEMA 10265.20Bullish
- DEMA 20267.01Bearish
- DEMA 50269.54Bearish
- DEMA 100263.05Bullish
- DEMA 200258.68Bullish
- TEMA 10265.41Bullish
- TEMA 20264.61Bullish
- TEMA 50270.82Bearish
- TEMA 100270.00Bearish
- TEMA 200254.49Bullish
- MACD0.58Bearish
- ADX14.90Weak Trend
- IndicatorValueSignal
- RSI50.89Neutral
- CCI-44.29Neutral
- ROC 140.08Bullish
- ROC 253.17Bullish
- Stoch K38.09Neutral
- Stoch D32.66Neutral
- IndicatorValueSignal
- BB Upper299.56Neutral
- BB Middle270.18Neutral
- BB Lower240.80Neutral
- ATR14.57High Volatility
- IndicatorValueSignal
- MFI55.21Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20255.30Bullish
- SMA 50251.39Bullish
- EMA 20258.41Bullish
- EMA 50250.28Bullish
- DEMA 20268.59Bullish
- DEMA 50262.84Bullish
- TEMA 20277.28Bearish
- TEMA 50255.42Bullish
- MACD8.74Bullish
- ADX12.11Weak Trend
- IndicatorValueSignal
- RSI53.79Neutral
- CCI76.90Neutral
- ROC 149.27Bullish
- ROC 2518.80Bullish
- Stoch K65.69Neutral
- Stoch D74.31Neutral
- IndicatorValueSignal
- BB Upper296.12Neutral
- BB Middle255.30Neutral
- BB Lower214.48Neutral
- ATR30.63High Volatility
- IndicatorValueSignal
- MFI56.06Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6247.64Bullish
- SMA 12257.60Bullish
- SMA 24245.81Bullish
- EMA 6262.42Bullish
- EMA 12253.42Bullish
- EMA 24230.91Bullish
- DEMA 6274.04Bullish
- DEMA 12269.31Bullish
- DEMA 24279.05Bullish
- TEMA 6283.95Bullish
- TEMA 12263.91Bullish
- TEMA 24278.12Bullish
- MACD54.81Bearish
- ADX24.96Weak Trend
- IndicatorValueSignal
- RSI61.11Neutral
- CCI105.83Overbought
- ROC 25103.33Bullish
- ROC 50265.05Bullish
- Stoch K66.14Neutral
- Stoch D72.39Neutral
- IndicatorValueSignal
- BB Upper315.83Neutral
- BB Middle251.24Neutral
- BB Lower186.65Neutral
- ATR58.65High Volatility
- IndicatorValueSignal
- MFI65.89Neutral